ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,688 Cr | ₹1,554 Cr | ₹1,225 Cr | ₹1,111 Cr | ₹1,237 Cr |
What is the latest Total Liabilities ratio of ORCHID PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹1,688 Cr |
| Mar2024 | ₹1,554 Cr |
| Mar2023 | ₹1,225 Cr |
| Mar2022 | ₹1,111 Cr |
| Mar2021 | ₹1,237 Cr |
How is Total Liabilities of ORCHID PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,688 Cr | 8.62 | |
| Mar2024 | ₹1,554 Cr | 26.83 | |
| Mar2023 | ₹1,225 Cr | 10.32 | |
| Mar2022 | ₹1,111 Cr | -10.24 | |
| Mar2021 | ₹1,237 Cr | - | |
Compare Total Liabilities of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹5,869.3 Cr | -5.2% | -4.1% | 27.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,394.0 Cr | -2.3% | -3.3% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,312.0 Cr | 0.3% | 16.3% | 44.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,678.0 Cr | 2.8% | -0.5% | 37.1% | Stock Analytics | |
| CIPLA | ₹114,392.0 Cr | -3.1% | -1.2% | -5.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,740.5 Cr | -2.9% | -3% | -3.3% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | -5.2% |
-4.1% |
27.4% |
| SENSEX | -1.4% |
-1% |
-4.6% |
You may also like the below Video Courses